CAPTRUST Financial Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$745K Buy
12,688
+5,025
+66% +$211K ﹤0.01% 1908
2026
Q1
$247K Buy
7,663
+567
+8% +$21K ﹤0.01% 2539
2025
Q4
$299K Buy
7,096
+1,237
+21% +$49.9K ﹤0.01% 2254
2025
Q3
$201K Buy
+5,859
New +$168K ﹤0.01% 2426
2025
Q1
Sell
-5,208
Closed -$206K 2463
2024
Q4
$206K Buy
+5,208
New +$197K ﹤0.01% 2127
2022
Q3
Sell
-626
Closed -$12K 3988
2022
Q2
$12K Buy
626
+230
+58% +$4.65K ﹤0.01% 3666
2022
Q1
$11K Buy
396
+192
+94% +$5.49K ﹤0.01% 3757
2021
Q4
$8K Sell
204
-111
-35% -$4.9K ﹤0.01% 3859
2021
Q3
$15K Buy
315
+106
+51% +$4.63K ﹤0.01% 3365
2021
Q2
$8K Sell
209
-88
-30% -$3.76K ﹤0.01% 3674
2021
Q1
$16K Buy
+297
New +$17.1K ﹤0.01% 3158

Other funds holding VCYT

CAPTRUST Financial Advisors's VCYT Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Veracyte (VCYT) stake by 66% in Q2 2026, buying an estimated $211K and bringing the position to 12,688 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #1908.

CAPTRUST Financial Advisors first reported a position in VCYT in Q1 2021 and has held it in 11 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • CAPTRUST Financial Advisors held 12,688 shares of Veracyte worth $745K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 5,025 Veracyte shares in Q2 2026, an estimated $211K.
  • Veracyte made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1908 holding.
  • CAPTRUST Financial Advisors first reported a position in Veracyte in Q1 2021 and has held it in 11 quarters since.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.